Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

3.380 -0.010 (-0.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sensus Healthcare, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Sensus Healthcare to Participate in the 36th Annual Roth Conference
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
From Sensus Healthcare, Inc.
Via GlobeNewswire
3 Stocks to Buy That Are Up 100% or More in 2024
While stocks up 100% don’t seem like a particularly great deal, these high-flying entities can still provide more rewards. 
Via InvestorPlace
Sensus Healthcare Inc. (NASDAQ: SRTS) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Recap: Sensus Healthcare Q4 Earnings
 
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Earnings Preview For Sensus Healthcare
 
Via Benzinga
Sensus Healthcare Inc. (NASDAQ: SRTS) Near the Top of Equities by Percentage Gain on 1/23
Via Investor Brand Network
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
From Sensus Healthcare, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare: Q3 Earnings Insights
 
Via Benzinga
Preview: Sensus Healthcare's Earnings
 
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates. 
Via Benzinga
Sensus Healthcare's Earnings: A Preview
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
From Sensus Healthcare, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
From Sensus Healthcare, Inc.
Via GlobeNewswire
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital
Continues SRT-100+™ customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancers 
From Sensus Healthcare, Inc.
Via GlobeNewswire
7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio
Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game. 
Via InvestorPlace
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Announces New $3 Million Share Repurchase Program
From Sensus Healthcare, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.